about
Multiple neurological abnormalities in mice deficient in the G protein GoPhloroglucinol protects retinal pigment epithelium and photoreceptor against all-trans-retinal-induced toxicity and inhibits A2E formationTranscription of the mouse PAC1 receptor gene: cell-specific expression and regulation by Zac1.Deafness and cochlear fibrocyte alterations in mice deficient for the inner ear protein otospiralin.Fatty acid transport protein 1 regulates retinoid metabolism and photoreceptor development in mouse retina.Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.Fatp1 deficiency affects retinal light response and dark adaptation, and induces age-related alterations.A truncated form of rod photoreceptor PDE6 β-subunit causes autosomal dominant congenital stationary night blindness by interfering with the inhibitory activity of the γ-subunit.PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance.Mutations in IMPG1 cause vitelliform macular dystrophies.Disruption of the G(i2) alpha locus in embryonic stem cells and mice: a modified hit and run strategy with detection by a PCR dependent on gap repair.VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.Screening genes of the visual cycle RGR, RBP1 and RBP3 identifies rare sequence variations.Dissociation between light-induced phase shift of the circadian rhythm and clock gene expression in mice lacking the pituitary adenylate cyclase activating polypeptide type 1 receptor.Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.Mice lacking the PACAP type I receptor have impaired photic entrainment and negative masking.Apical localization of the alpha subunit of GTP-binding protein Go in choroidal and ciliated ependymocytes.Impaired somatodendritic responses to pituitary adenylate cyclase-activating polypeptide (PACAP) of supraoptic neurones in PACAP type I -receptor deficient mice.Altered social behavior in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice.Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system.Inactivation of the G alpha i2 and G alpha o genes by homologous recombination.Granule cell survival is deficient in PAC1-/- mutant cerebellum.Immunocytochemical localization of the guanine nucleotide-binding protein Go in primary cultures of neuronal and glial cells.PAC1 null females display decreased fertility.Immunological localization of the GTP-binding protein Go in different tissues of vertebrates and invertebrates.Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice.Physiological and pathological roles of FATP-mediated lipid droplets in Drosophila and mice retinaNew Lipophenol Antioxidants Reduce Oxidative Damage in Retina Pigment Epithelial Cells[Monoclonal antibodies obtained against G-protein epitopes: comparison of immunoreactions seen in the brain, retina and striated muscular tissue]Gi2 alpha protein deficiency: a model of inflammatory bowel diseaseCharacterization of intestinal receptors for VIP and PACAP in rat and in PAC1 receptor knockout mouseNerve growth factor upregulates the PAC1 promoter by activating the MAP kinase pathway in rat PC12 cellsInduction of type I PACAP receptor expression by the new zinc finger protein Zac1 and p53Simple and efficient: validation of a cotton wick electrode for animal electroretinographyBis-allylic Deuterated DHA Alleviates Oxidative Stress in Retinal Epithelial CellsIsopropyl-phloroglucinol-DHA protects outer retinal cells against lethal dose of all-trans-retinalNatural models for retinitis pigmentosa: progressive retinal atrophy in dog breedsAdvanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy
P50
Q28585725-C3969F34-C534-497A-A0D1-F3CEBAA12961Q28830034-4910D4C2-CA4A-42C8-B842-02ADD2C3744EQ31062590-43516023-0E10-41B9-9009-08DE48A693D8Q33695098-056532C7-794C-4EC8-9B58-705FAFA2822CQ33865720-3F1AB268-27CC-4AB0-81C9-018B4AF25CD3Q33894893-C1C846FF-E09E-4283-BD3F-D2581B0F5A1BQ34483100-B2D2DCBA-24D0-4CCC-946E-0AA2BC13E6E2Q35156268-27295764-0EDD-4EEB-BA41-3DF499247F41Q35159144-601E2E78-843D-41ED-A827-B03DDBD2750BQ37162558-3345AC68-4F94-4EC7-BDA2-6EA7AD64842CQ38314638-0AF26590-DC92-4CF9-900F-768CD6827DC9Q42655438-617B2324-DDBC-43C7-BC48-48FB88B0044AQ42822798-381AB95D-C323-41E6-8CC7-F9DCA7E7F16AQ43653434-1BCE8660-1825-4AE1-B857-ECABB11627D8Q43919971-1E1851F1-4203-4245-8643-B2070C0FE306Q43995519-8132E77C-DC0D-4C3D-9BF7-0B7AAB1EF640Q44483016-689D787D-3786-4FFC-9735-7424C620BB08Q44537622-B73F262A-7C39-4FEA-B2EB-9F5F656449C0Q45094902-CFB18A91-D5A1-4B38-9359-1D082F4BE209Q45190302-EA1A15F9-6036-4349-9A2B-C72BCD790038Q46399968-E5CE3348-A35D-4B43-BEE0-7203051F2A01Q46428997-6E73B21A-5370-4314-9A59-79D7CE242239Q46647393-CD1D8D33-DE57-4F25-8F1F-EE718286D29BQ48119311-49701F49-2694-4261-ACCE-E99031C4A8D7Q49010673-615AD3A0-4621-4103-938B-9C632F26C67CQ52458887-8A59F170-D10F-42F8-847B-C87D37521A30Q53463453-3EE0D769-B498-4767-8AAC-DA6E44FB7A29Q58753845-77F483C5-128C-401D-A561-5BD820FC51A4Q60945832-69493462-D1F9-4EEB-9C33-45CACC394FA0Q67686836-C427A20C-CE23-47C9-8B3A-04D7EF29E005Q71037739-044DF387-4B7B-41BD-8DB8-B2806DCD4E73Q73476374-C705F107-3E79-47EC-BE99-73BBB2635E5AQ73476489-5C14E401-25B0-4120-BB76-E12825796657Q77934825-DF8EC839-18AF-4B6A-8603-5E8F23804FA3Q82317378-8B4952E4-1AB7-469D-90E1-EBA91BF80081Q90460516-B8E69BCD-C54A-44A4-9BB4-CAF90F1CBB9AQ90650301-431D35DE-9143-47E9-8E72-E8BC2CAAB13CQ92575748-95514AD3-55BF-4C4E-83D5-0A13516DEFC6Q95280291-C16B12F2-6118-4AB6-A9BF-08543E80FE5B
P50
description
researcher ORCID ID = 0000-0003-2739-1622
@en
wetenschapper
@nl
name
Philippe Brabet
@ast
Philippe Brabet
@en
Philippe Brabet
@es
Philippe Brabet
@nl
type
label
Philippe Brabet
@ast
Philippe Brabet
@en
Philippe Brabet
@es
Philippe Brabet
@nl
prefLabel
Philippe Brabet
@ast
Philippe Brabet
@en
Philippe Brabet
@es
Philippe Brabet
@nl
P106
P31
P496
0000-0003-2739-1622